ALSO: Success in One of the 2024’s Most Anticipated Clinical Trials; New AI-Docking Engine Goes Open-source; 2024 State of CRISPR Clinical Trials; AlfaFold 3 is Great, But Use With Care
Weekly Tech+Bio Highlights #2
ALSO: Success in One of the 2024’s Most Anticipated Clinical Trials; New AI-Docking Engine Goes Open-source; 2024 State of CRISPR Clinical Trials; AlfaFold 3 is Great, But Use With Care